Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (191-200 of 349) with videos related to

Pageof 35
Sort By:
Urology|October 18, 2002
Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigenLori J Sokoll, Debra J Bruzek, Renu Dua, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2006
Metabolic factors associated with benign prostatic hyperplasiaJ Kellogg Parsons, H Ballentine Carter, Alan W Partin, et al.
Regional Anesthesia and Pain Medicine|June 12, 2014
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational studyKenneth S Tseng, Sachin Kulkarni, Elizabeth B Humphreys, et al.
Urology|October 31, 2006
Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancerRobert W Veltri, Masood A Khan, Cameron Marlow, et al.
Urology|December 22, 2015
Prostate Health Index (PHI) Predicts High-stage Pathology in African American MenZeyad R Schwen, Jeffrey J Tosoian, Lori J Sokoll, et al.
BJU International|November 15, 2008
Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level aloneDavid J Hernandez, Misop Han, Elizabeth B Humphreys, et al.
BJU International|July 13, 2020
Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trialMitchell M Huang, Zhuo T Su, Russell E N Becker, et al.
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceJeffrey J Tosoian, Bruce J Trock, Patricia Landis, et al.
Pageof 35

Showing results (191-200 of 349) with videos related to

Sort By:
Pageof 35
Urology|October 18, 2002
Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigenLori J Sokoll, Debra J Bruzek, Renu Dua, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2006
Metabolic factors associated with benign prostatic hyperplasiaJ Kellogg Parsons, H Ballentine Carter, Alan W Partin, et al.
Regional Anesthesia and Pain Medicine|June 12, 2014
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational studyKenneth S Tseng, Sachin Kulkarni, Elizabeth B Humphreys, et al.
Urology|October 31, 2006
Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancerRobert W Veltri, Masood A Khan, Cameron Marlow, et al.
Urology|December 22, 2015
Prostate Health Index (PHI) Predicts High-stage Pathology in African American MenZeyad R Schwen, Jeffrey J Tosoian, Lori J Sokoll, et al.
BJU International|November 15, 2008
Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level aloneDavid J Hernandez, Misop Han, Elizabeth B Humphreys, et al.
BJU International|July 13, 2020
Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trialMitchell M Huang, Zhuo T Su, Russell E N Becker, et al.
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceJeffrey J Tosoian, Bruce J Trock, Patricia Landis, et al.
Pageof 35